WARRANT AGENCY AGREEMENT
WARRANT AGENCY AGREEMENT, dated as of April 27, 2022 (“Agreement”), between Clarus Therapeutics Holdings, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and Continental Stock Transfer & Trust LLC (the “Warrant Agent”).
W I T N E S S E T H
WHEREAS, pursuant to a registered offering by the Company of 31,361,328 Units (the “Offering”), with each Unit consisting of one share of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) or one pre-funded warrant (the “Pre-Funded Warrant”) to purchase one share of Common Stock at an exercise price of $0.001 per share of Common Stock and one warrant (together with the Pre-Funded Warrants, the “Warrants”) to purchase one share of Common Stock (the “Warrant Shares”) at a price of $1.023 per Unit (representing a 7% discount of the price of each share of Common Stock sold in the Offering); and
WHEREAS, the Company granted to the underwriters an over-allotment option to purchase up to an additional 4,090,608 shares of common stock at a per share price of $1.0137 and/or up to an additional 4,090,608 Warrants to purchase up to 4,090,608 Warrant Shares at a price per Warrant of $1.0221, less, in each case, any underwriting discounts and commissions, if any; and
WHEREAS, upon the terms and subject to the conditions hereinafter set forth and pursuant to (i) an effective registration statement on Form S-1, as amended (File No. 333-264231) (the “Initial Registration Statement”), and (ii) an additional effective registration statement on Form S-1 (File No. 333-264465) filed pursuant to Rule 462(b) promulgated under the Securities Act (the “462(b) Registration Statement”, and together with the Initial Registration Statement, the “Registration Statement”), and the terms and conditions of the Warrant Certificate, the Company wishes to issue the Warrants in book entry form entitling the respective holders of the Warrants (the “Holders,” which term shall include a Holder’s transferees, successors and assigns and “Holder” shall include, if the Warrants are held in “street name,” a Participant (as defined below) or a designee appointed by such Participant); and
WHEREAS, the shares of Common Stock and Warrants to be issued in connection with the Offering shall be immediately separable and will be issued separately, but will be purchased together in the Offering; and
WHEREAS, the Company wishes the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing so to act, in connection with the issuance, registration, transfer, exchange, exercise and replacement of the Warrants and, in the Warrant Agent’s capacity as the Company’s transfer agent, the delivery of the Warrant Shares (as defined below).
NOW, THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the parties hereby agree as follows:
Section 1. Certain Definitions. For purposes of this Agreement, all capitalized terms not herein defined shall have the meanings hereby indicated:
(a) “Affiliate” has the meaning ascribed to it in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
(b) “Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which the Nasdaq Stock Market is authorized or required by law or other governmental action to close.
(c) “Close of Business” on any given date means 5:00 p.m., New York City time, on such date; provided, however, that if such date is not a Business Day it means 5:00 p.m., New York City time, on the next succeeding Business Day.
2